Sufugolix

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSufugolix
Drug Alias NameTAK 013TAK-013
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGonadotropin-releasing hormone antagonists
TargetsGonadotropin-releasing hormone
Therapy Area/IndicationsEndometriosisLeiomyoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsEndometriosisLeiomyoma

Other Information

ATC CodeN/A
Related LinksN/A